PICKERING, ON, May 15, 2014 /CNW/ – Purdue Pharma (Canada) today announced the appointment of Grant Perry to the position of Vice President, Corporate and Government Affairs, effective May 15, 2014. In this role, Mr. Perry will also be responsible for the development and implementation of strategies to ensure appropriate patient access to Purdue’s current and future marketed products. Mr. Perry reports to Dr. Craig Landau, President and CEO, and will be a key member of Purdue’s executive leadership team.
Mr. Perry comes to Purdue from GlaxoSmithKline (GSK) where he spent the last 15 years, most recently as Vice President, Public Affairs and Reimbursement. He previously held leadership roles within the primary care pharmaceutical and vaccine businesses of GlaxoSmithKline, contributing to the success of the business both in Canada and abroad. Along with his broad experience with GSK, Grant’s background includes roles with Industry Canada and the Pharmaceutical Manufacturers Association of Canada (now known as Rx&D).
According to Dr. Landau, “Grant’s impressive work in policy, patient advocacy and market access at both the federal and provincial levels has earned him the reputation of being among the top in his field. His many years of experience and proven record of accomplishment will help Purdue pursue new growth opportunities, while solidifying its position as the leading innovative analgesic pharmaceutical company in Canada.”
About Purdue Pharma (Canada)
Purdue Pharma (Canada) (www.purdue.ca) is a research-based pharmaceutical company with its headquarters and manufacturing operations located in Pickering, Ontario. The company is a leader in the research and development of medicines for the treatment of pain. Privately held, Purdue Pharma (Canada) is independently associated with the worldwide Purdue/Napp/Mundipharma group of companies.